researchchem bpc 157 BPC-157: A Prohibited Peptide and an Unapproved Drug Found in Health and Wellness Products BPC-157 Analytical Reference Standard |

Trial averages at the highest dose (12 mg) reached around 24% body weight loss at 48 weeks, and around 28% at 68 weeks in the obesity plus knee osteoarthritis trial

All experimental procedures were approved by the Washington State University Animal Care and Use Committee

Dihexa has gained attention for its potential to enhance neurotrophic activity, which is crucial for the growth and maintenance of nerve cells in the brain

Anti-inflammatory activity appears linked to its ability to reduce tissue damage and improve blood flow to affected areas, which supports repair processes

Thony B, Calvo AC, Scherer T, Svebak RM, Haavik J, Blau N, et al